Annual report with a comprehensive overview of the company - Form 10-K

IR Nav

SEC Filing For null
 CURE PHARMACEUTICAL HOLDING CORP. - 10-K (Filed: 26-03-2018) Close Window
Sub Document 1
Page 1: UNITED STATES
Page 4: PART I
Page 9: PART II
Page 10: Dividends
Page 12: BUSINESS
Page 14: RESULTS
Page 22: PART III
Page 25: Term of Office
Page 35: (cont'd)
Page 36: (cont'd)
Page 37: (cont'd)
Page 38: (cont'd)
Page 40: Acquisitions
Page 43: Going Concern
Page 55: SIGNATURES
Sub Document 2
Page 1: EXHIBIT 10.5
Page 2: Common Stock
Page 3: SEC
Page 4: ARTICLE II
Page 5: ARTICLE III
Page 6: Authorization
Page 8: Litigation
Page 12: Purchaser Status
Page 13: ARTICLE IV
Page 16: Form D
Page 17: Entire Agreement
Page 21: (cont'd)
Page 22: (cont'd)
Sub Document 3
Page 1: EXHIBIT 10.5.1
Page 2: Business Day
Page 9: Notices
Page 10: Waiver
Page 11: (cont'd)
Page 12: ANNEX A
Sub Document 4
Page 1: EXHIBIT 10.5.2
Page 2: Exercise
Page 6: New Warrants
Page 7: Saturdays
Page 8: Notices
Page 9: (cont'd)
Page 11: (cont'd)
Page 12: ASSIGNMENT FORM
Sub Document 5
Page 1: EXHIBIT 31.1
Sub Document 6
Page 1: EXHIBIT 31.2
Sub Document 7
Page 1: EXHIBIT 32.1
Sub Document 8
Page 1: EXHIBIT 32.2
Sub Document 9
Sub Document 10
Sub Document 11
Sub Document 12
Sub Document 13
Sub Document 14
Sub Document 15

Copyright © 2018 QuoteMedia. All rights reserved. Terms of Use.
Market Data powered by QuoteMedia, www.quotemedia.com, SEC filings by Morningstar.

IR website by IR WebKit